Since quite ago, it is known that anti-inflammatory agents may have clinical benefits in preventing cardiovascular disease, in view of the direct relation existing between markers of a general inflammatory status, like C-reactive protein, and the risk of cardiovascular diseases [77]. The gene discussed is CRP; the disease is cardiovascular disorder.